NCT05197556: A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients |
|
|
| Completed | 2 | 81 | RoW | HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo | Glaceum, Gangnam Severance Hospital, Seoul National University Bundang Hospital, Korea University Anam Hospital, Seoul National University Hospital, SMG-SNU Boramae Medical Center | Obesity | 12/22 | 04/23 | | |
NCT06329141: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients |
|
|
| Not yet recruiting | 2 | 90 | NA | Vutiglabridin, HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo | Glaceum, The Catholic University of Korea, Kyunghee University Medical Center, Korea University Guro Hospital, Samsung Medical Center, Severance Hospital, Inje University | Parkinson Disease | 12/25 | 06/26 | | |
